Reference
Shalata W, et al. A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors. Cancers 14: No. 21, et al. Nov 2022. Available from: URL: http://doi.org/10.3390/cancers14215451
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1980, 47 (2023). https://doi.org/10.1007/s40278-023-48239-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-48239-4